ArticleNeurosurgical review2025
The role of thrombin time as an independent variable in predicting In-Stent stenosis risk after flow diverter treatment for intracranial aneurysms: a retrospective cohort study.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Unruptured intracranial aneurysms are common neurovascular diseases, and flow diverters (FDs) have emerged as a key treatment modality. However, in-stent stenosis (ISS) remains a frequent complication after FD treatment, increasing the risk of thromboembolic events. Thrombin time (TT), a critical coagulation indicator, has potential associations with ISS risk. The objective of this study was to investigate the relationship between TT and ISS risk, with a focus on potential threshold effects. This multicenter retrospective cohort study included 389 patients with unruptured intracranial aneurysms treated with FD between March 2016 and October 2024. The primary exposure was preoperative TT, and the primary outcome was ISS occurrence during follow-up. Generalized additive models were used to explore non-linear relationships, while segmented linear regression identified threshold points. ISS occurred in 22.62% (88/389) of patients. TT exhibited a non-linear relationship with ISS risk, with a threshold of 19.2 s. For TT values below this threshold, each unit increase was associated with a 59% higher likelihood of developing ISS (OR = 1.59, 95% CI: 1.19-2.13, p = 0.002). These findings may help identify patients at higher risk for ISS who could benefit from more intensive angiographic follow-up with shortened intervals, enabling earlier detection and timely intervention.
Indexed as
Identifiers
41134383What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.